1. Inhibition of calcineurin combined with dasatinib has direct and indirect anti‐leukemia effects against BCR‐ABL1+ leukemia. Issue 9 (19th June 2014) Authors: Gardner, Lori A.; Klawitter, Jelena; Gregory, Mark A.; Zaberezhnyy, Vadym; Baturin, Dmitry; Pollyea, Daniel A.; Takebe, Naoko; Christians, Uwe; Gore, Lia; DeGregori, James; Porter, Christopher C. Journal: American journal of hematology Issue: Volume 89:Issue 9(2014:Sep.) Page Start: 896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗